跳至主要内容
临床试验/NCT06279884
NCT06279884尚未招募不适用

A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of Liver Transplant Recipients Complicated With Infection

Zhejiang University0 个研究点目标入组 1,000 人开始时间: 2024年3月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,000
主要终点
Secondary Infections in liver transplant recipients at 4 weeks

研究概览

简要总结

The goal of this observational study is to map the pathogen profile of secondary infections in liver transplant recipients, to correlate the basic immune status with the characteristics of the secondary infection pathogen profile, and to establish an early warning system for monitoring secondary infections, so as to explore safe and effective therapeutic modalities to further reduce the morbidity and mortality of liver failure. The main questions it aims to answer are:

  • Characterize the distribution of pathogenic bacteria infecting liver transplant recipients.
  • Establish a monitoring and early warning system for secondary infections.

详细描述

Liver transplantation is recognized as the most effective treatment for end-stage liver disease, and China's liver transplantation technology has reached the international level, with survival rates of 90%, 80%, and 70% at 1, 5, and 10 years after surgery, respectively. During the perioperative period of liver transplantation, transplant recipients with preoperative organ dysfunction, high surgical trauma, postoperative application of immunosuppressive drugs, and low anti-infective capacity are highly susceptible to associated infections, which are more likely to occur than in other transplant recipients, and have become an important factor affecting the prognosis of liver transplantation. Foreign studies reported that 18% of postoperative liver transplantation deaths were caused by infections, of which bacterial infections were the most common, followed by viral and fungal infections. In the first month after liver transplantation, the incidence of infection is the highest, and bacterial pneumonia is the most common infection, with a high case fatality rate, and the hospitalization time of the patient is significantly prolonged, and the economic expenditure is increased. Early clarification of the type and distribution of pathogenic bacteria infecting liver transplant recipients and prompt initiation of appropriate anti-infective therapy are essential to improve the survival of liver transplant recipients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Agree to participate in this study and sign the informed consent form;
  • Be of any gender and aged 18-70 years old;
  • No life-threatening underlying diseases and complications during the perioperative period.
  • Undergo liver transplantation within 24 hours.

排除标准

  • 1.Patients deemed unsuitable by the investigator to participate in the study.

结局指标

主要结局

Secondary Infections in liver transplant recipients at 4 weeks

时间窗: 4 weeks

Site of infection, pathogen results such as blood or body fluid pathogen cultures or Next-generation sequencing(NGS) results.

quick SEPSIS RELATED ORGAN FAILURE ASSESSMENT(qSOFA) at 4 weeks

时间窗: 4 weeks

qSOFA consists of 3 items: altered state of consciousness, systolic blood pressure ≤ 100 mmHg, and respiratory rate ≥ 22 respirations/min. 2 or more items, i.e., a qSOFA score of ≥ 2, are considered to be suspicious for sepsis.Higher qSOFA scores are associated with a higher risk of patient death.

次要结局

  • Occurrence of secondary infections in liver transplant recipients at 12 weeks, including site of infection, pathogen of infection(12 weeks)
  • qSOFA score at 8 weeks(8 weeks)
  • qSOFA score at 12 weeks(12 weeks)
  • Occurrence of secondary infections in liver transplant recipients at 8 weeks, including site of infection, pathogen of infection(8 weeks)

研究者

发起方
Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiajia Chen

Chief Physician of the First Affiliated Hospital,Zhejiang University School of Medicine

Zhejiang University

相似试验